An Open-label Study to Assess the Safety and Efficacy of Concurrent Administration of Two Injections of AA4500 0.58 mg Into the Same Hand of Subjects With Multiple Dupuytren's Contractures
Phase of Trial: Phase III
Latest Information Update: 11 Jul 2015
Price : $35 *
At a glance
- Drugs Collagenase clostridium histolyticum (Primary)
- Indications Dupuytren's contracture
- Focus Registrational; Therapeutic Use
- Sponsors Auxilium Pharmaceuticals
- 08 May 2014 According to a Biospecifics Technologies Corporation media release, the supplement biologics license application (sBLA) for potential label expansion of Xiaflex is under FDA review with a PDUFA date of October 20, 2014.
- 18 Oct 2013 New trial record
- 07 Oct 2013 Analysis on the use of local anaesthesia reported in a BioSpecifics Technologies Corporation media release and presented at the 68th Annual Meeting of the American Society for Surgery of the Hand (ASSH).